Fig. 7From: Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case reportTherapeutic effect on the primary lesion and lung metastasis under immunotherapyBack to article page